Exelon Corporation

NasdaqGS:EXC Voorraadrapport

Marktkapitalisatie: US$38.3b

Exelon Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Exelon heeft een totaal eigen vermogen van $26.6B en een totale schuld van $46.1B, wat de schuld-eigenvermogensverhouding op 173.2% brengt. De totale activa en totale passiva bedragen respectievelijk $106.1B en $79.4B. De EBIT Exelon is $4.3B waardoor de rentedekking 2.2 is. Het heeft contanten en kortetermijnbeleggingen van $616.0M.

Belangrijke informatie

173.2%

Verhouding schuld/eigen vermogen

US$46.12b

Schuld

Rente dekkingsratio2.2x
ContantUS$616.00m
AandelenUS$26.62b
Totaal verplichtingenUS$79.45b
Totaal activaUS$106.07b

Recente financiële gezondheidsupdates

Recent updates

Here's Why We Think Exelon (NASDAQ:EXC) Might Deserve Your Attention Today

Oct 22
Here's Why We Think Exelon (NASDAQ:EXC) Might Deserve Your Attention Today

A Look At The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)

Oct 04
A Look At The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)

Exelon Is A Reasonably Priced Utility For Income Investors

Sep 24

There Is A Reason Exelon Corporation's (NASDAQ:EXC) Price Is Undemanding

Aug 25
There Is A Reason Exelon Corporation's (NASDAQ:EXC) Price Is Undemanding

Exelon: Shares Still Undervalued, But Now With Higher Dividend And New Growth Potential

Jul 08

Earnings Miss: Exelon Corporation Missed EPS By 5.8% And Analysts Are Revising Their Forecasts

May 05
Earnings Miss: Exelon Corporation Missed EPS By 5.8% And Analysts Are Revising Their Forecasts

Exelon Corporation's (NASDAQ:EXC) Shareholders Might Be Looking For Exit

Apr 29
Exelon Corporation's (NASDAQ:EXC) Shareholders Might Be Looking For Exit

Exelon: Rate-Base Scale, Cost Management Drive Upside Potential

Mar 29

A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)

Mar 18
A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)

Risks To Shareholder Returns Are Elevated At These Prices For Exelon Corporation (NASDAQ:EXC)

Jan 08
Risks To Shareholder Returns Are Elevated At These Prices For Exelon Corporation (NASDAQ:EXC)

A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)

Oct 27
A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)

Are Exelon Corporation (NASDAQ:EXC) Investors Paying Above The Intrinsic Value?

Jul 24
Are Exelon Corporation (NASDAQ:EXC) Investors Paying Above The Intrinsic Value?

Exelon (NASDAQ:EXC) Is Increasing Its Dividend To $0.36

Apr 29
Exelon (NASDAQ:EXC) Is Increasing Its Dividend To $0.36

Exelon Corporation's (NASDAQ:EXC) Intrinsic Value Is Potentially 21% Below Its Share Price

Apr 10
Exelon Corporation's (NASDAQ:EXC) Intrinsic Value Is Potentially 21% Below Its Share Price

Exelon's (NASDAQ:EXC) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 18
Exelon's (NASDAQ:EXC) Shareholders Will Receive A Bigger Dividend Than Last Year

Does This Valuation Of Exelon Corporation (NASDAQ:EXC) Imply Investors Are Overpaying?

Dec 30
Does This Valuation Of Exelon Corporation (NASDAQ:EXC) Imply Investors Are Overpaying?

Estimating The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)

Sep 26
Estimating The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)

Exelon: A Pure Play Transmission Firm Poised To Benefit From Utility Grid Transformation

Aug 31

Exelon Q2 2022 Earnings Preview

Aug 02

We Think Exelon (NASDAQ:EXC) Is Taking Some Risk With Its Debt

Aug 01
We Think Exelon (NASDAQ:EXC) Is Taking Some Risk With Its Debt

Exelon Corporation declares $0.3375 dividend

Jul 26

A Look At The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)

Jun 21
A Look At The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)

Exelon's Corporate Transactions Will Likely Imply Higher Stock Price

May 17

Exelon (NASDAQ:EXC) Has A Somewhat Strained Balance Sheet

May 02
Exelon (NASDAQ:EXC) Has A Somewhat Strained Balance Sheet

Exelon Corporation: On The Verge Of Proving Its Worth

Apr 15

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $8.0B ) EXC } overtreffen de korte termijn passiva ( $7.4B ).

Langlopende schulden: De kortetermijnactiva van EXC ( $8.0B ) dekken de langetermijnschulden ( $72.1B ) niet.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 170.9% ) EXC wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van EXC is de afgelopen 5 jaar gestegen van 109.8% naar 173.2%.

Schuldendekking: De schuld van EXC wordt niet goed gedekt door de operationele kasstroom ( 12% ).

Rentedekking: De rentebetalingen van EXC op haar schulden worden niet goed gedekt door EBIT ( 2.2 x dekking).


Balans


Ontdek gezonde bedrijven